Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway by Hoffman, Lucas R. et al.
Nutrient Availability as a Mechanism for Selection of
Antibiotic Tolerant Pseudomonas aeruginosa within the
CF Airway
Lucas R. Hoffman
1, Anthony R. Richardson
2, Laura S. Houston




3, Jane L. Burns
1, David A. Stahl
4, Daniel J. Hassett
5, Ferric C.
Fang
2,6,7, Samuel I. Miller
2,3,6*
1Department of Pediatrics, University of Washington, Seattle, Washington, United States of America, 2Department of Microbiology, University of Washington, Seattle,
Washington, United States of America, 3Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America, 4Department of Civil
and Environmental Engineering, University of Washington, Seattle, Washington, United States of America, 5Department of Molecular Genetics, Biochemistry and
Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America, 6Department of Medicine, University of Washington, Seattle,
Washington, United States of America, 7Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America
Abstract
Microbes are subjected to selective pressures during chronic infections of host tissues. Pseudomonas aeruginosa isolates with
inactivating mutations in the transcriptional regulator LasR are frequently selected within the airways of people with cystic
fibrosis (CF), and infection with these isolates has been associated with poorer lung function outcomes. The mechanisms
underlying selection for lasR mutation are unknown but have been postulated to involve the abundance of specific nutrients
within CF airway secretions. We characterized lasR mutant P. aeruginosa strains and isolates to identify conditions found in CF
airways thatselectforgrowthof lasRmutants. Relative to wild-typeP.aeruginosa, lasRmutants exhibiteda dramaticmetabolic
shift, including decreased oxygen consumption and increased nitrate utilization, that is predicted to confer increased fitness
within the nutrient conditions known to occur in CF airways. This metabolic shift exhibited by lasR mutants conferred
resistance to two antibiotics used frequently in CF care, tobramycin and ciprofloxacin, even under oxygen-dependent growth
conditions, yet selection for these mutants in vitro did not require preceding antibiotic exposure. The selection for loss of LasR
function invivo, and theassociatedadverse clinicalimpact,could beduetoincreasedbacterialgrowth intheoxygen-poor and
nitrate-rich CF airway, and from the resulting resistance to therapeutic antibiotics. The metabolic similarities among diverse
chronic infection-adapted bacteria suggest a common mode of adaptation and antibiotic resistance during chronic infection
that is primarily driven by bacterial metabolic shifts in response to nutrient availability within host tissues.
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Introduction
Microbes are subjected to selection in host environments during
the course of chronic infections [1,2,3]. The characteristics selected
may have profound impacts on disease outcomes, particularly if
they confer increased microbial fitness or resistance to therapy. One
example of this phenomenon is the adaptation of Pseudomonas
aeruginosa within the airways of people with cystic fibrosis (CF).
Diverse phenotypic changes have been observed among CF chronic
P. aeruginosa infection isolates, including changes in several surface
antigens [4,5], altered antibiotic susceptibilities [6], and overpro-
duction of the mucoid exopolysaccharide alginate [3]. P. aeruginosa
CF adaptive changes have been associated with poor clinical
outcomes [7,8] and, in the case of mucoidy, a diminished likelihood
of eradication by antibiotics [9].
Recently, several groups have described P. aeruginosa CF isolates
with inactivating mutations in the gene lasR [2,8,10,11,12].
Genetic analyses demonstrated that these mutants emerged from
existing, chronically-infecting lineages, as opposed to representing
new infections, and that multiple lineages with independent lasR
mutations occurred within individual patients, indicative of strong
selective pressure against LasR function [2,11]. lasR encodes a
central regulator of the bacterial intercellular signaling system
known as quorum sensing that requires the synthesis and
recognition of P. aeruginosa small molecule products, including
acyl-homoserine lactones (AHL). lasR mutant isolates occur in at
least one-third of P. aeruginosa culture-positive individuals younger
than 15 years attending CF clinics in Seattle [2,8]. Among this
population, lasR mutant isolates emerged relatively early during
CF airway infection (on average 2 years before mucoidy), and were
associated with worse lung function [8]. LasR inactivation
conferred distinct phenotypic consequences, including distinctive
colony morphology (autolysis and surface iridescent sheen) that
facilitates the identification of mutant isolates, a growth advantage
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increased b-lactamase enzyme activity [2,11]. These growth
phenotypes suggested that selection may be due to exposure to
antibiotics and nutrient availability within the CF airway. The
latter possibility was further indicated by altered growth in specific
nitrogen sources by lasR mutants compared with their wild-type
counterparts [11].
AHL signaling was shown previously by transcriptional
microarray [14] and enzymatic analyses [15,16] to regulate the
P. aeruginosa nitrogen metabolic pathway known as denitrification
(Fig. 1A). However, the las system comprises only a portion of the
complex AHL regulon, and the metabolic consequences of LasR
inactivation were not defined previously. Previous evidence from a
global physiological analysis of clinical isolates indicated that lasR
mutation could confer a growth advantage in the denitrification
substrates nitrate (NO3
2) and nitrite (NO2
2) [11], suggesting that
lasR mutant P. aeruginosa cells may exhibit increased utilization of
NO3
2 and NO2
2 as electron acceptors. Conversely, LasR
inactivation conferred sensitivity to high concentrations of NO2
2
among these isolates [11], as would be predicted if lasR mutant
cells avidly metabolize NO2
2 to nitric oxide (NO?), the chief toxic
metabolic side-product of denitrification (Fig. 1A).
The airways of people with CF are known to contain abundant
concentrations of NO3
2 and other nitrogen species [17,18], while
the concentrations of NO? (an important antimicrobial component
of host innate immunity) are usually significantly lower than in
people without CF for as yet unknown reasons [19]. In addition,
CF secretions infected with P. aeruginosa include areas with very low
molecular oxygen tensions [20]. These conditions would tend to
favor the use among infecting microbes of nitrogen oxides as
electron acceptors at the expense of oxygen utilization [16,21].
Thus, we hypothesized that lasR mutant P. aeruginosa cells have
respiratory alterations favoring growth in the nitrogen and oxygen
conditions characteristic of CF airways. Since many antibiotics
work best under aerobic conditions [22,23], such a metabolic shift
could adversely affect susceptibility (and thus clinical response) to
antibiotics. To test these hypotheses, we defined the consequences
of lasR mutation with respect to nitrate and oxygen metabolism, as
well as antibiotic susceptibility, in laboratory strains and CF
clinical isolates of P. aeruginosa.
Results
lasR mutants have a growth advantage in NO3
2 and
accumulate the toxic metabolite nitric oxide (NO?)
Given the evidence that lasR mutants may have a growth
advantage in NO3
2 [11], we compared the growth of P. aeruginosa
laboratory strain PA14 and clinical isolates carrying wild-type lasR
alleles with their derived lasR mutant strains in the presence of
various concentrations of NO3
2. lasR mutants exhibited a
substantial growth advantage in minimal medium with added
NO3
2. As shown in Fig. 1B for a lasR mutant with a gentamicin
insertion cassette derived from PA14 (PA14-lasR::Gm), a growth
advantage was detected in NO3
2 concentrations as low as
125 mM, well below the average NO3
2 concentrations recently
measured in CF airway secretions [17,18], and the advantage was
more pronounced at higher NO3
2 concentrations (not shown).
The average rate of lasR mutant growth (calculated as the slopes of
lines fit to the datasets shown between 8 and 16 minutes) in
50 mM NO3
2 was increased ,5-fold relative to wild-type. Similar
results were obtained using Luria Broth, with PA14 with an
unmarked lasR deletion (PA14DlasR), and with paired lasR wild-
type and mutant clinical isolates (not shown). This analysis
confirms and extends our previous finding that lasR mutations
confer a growth advantage with nitrogen sources that are
abundant in the CF airway, including NO3
2, as well as with
aromatic amino acids [11].




2, at significantly higher rates than did wild-type
strains and isolates (Fig. 1C). For example, the average rate of
NO2
2 production by lasR mutant strains was ,4.4-fold greater
than by wild-type. In contrast, lasR mutant strains and isolates
demonstrated a relatively modest spontaneous increase in NO?
reduction relative to wild-type (Fig. 1D); slopes for lines fit to each
dataset in Fig. 1D between 25 and 100 seconds demonstrated that
lasR mutant cells had an NO? degradation rate only ,1.8-fold
greater than wild-type cells. These activities resulted in dramat-
ically higher levels of NO? (Fig. 1E) in lasR mutant cultures that
could not be explained by any concurrent difference in growth
rates between lasR mutants and wild-type in added NO3
2
(compare Figs. 1B and 1E). The accumulation of NO?, a potent
microbicide [24], in lasR mutant cultures would be predicted to
result in cell death at very high cell densities (as observed with P.
aeruginosa cells with mutations in the quorum sensing regulator rhlR
[16]) and in increased susceptibility to exogenous NO? sources.
lasR mutation confers increased susceptibility to
nitrosative stress, and selection requires a membrane-
bound NO3
2 reductase
Because lasR mutant P. aeruginosa produces elevated levels of
endogenous NO?, and bacterial cells possess a finite capacity for
detoxifying NO? that can be exceeded by exposure to exogenous
reactive nitrogen species (RNS) [25], we predicted that lasR
mutants would also be more susceptible to the exogenous
nitrosative stress presented by either NO? donors (which have
relatively short aqueous half-lives [26]) or acidified NO2
2 (with
substantially greater aqueous half-life [27]). Therefore, lasR
mutant strains and isolates were tested for these susceptibility
phenotypes. lasR mutants were more susceptible to growth
inhibition by the addition of NO? donor compounds to liquid
cultures (Fig. 2A), and by NO2
2 disks during growth on acidified
agar medium (Fig. 2B). These results are in agreement with our
previous phenotype array findings that lasR inactivation in clinical
P. aeruginosa isolates confers increased susceptibility to high
concentrations of NO2
2 in unbuffered liquid minimal medium
Author Summary
Chronic infections are distinguished from many other
infections in that they are difficult to eradicate with
antibiotics. Thus, the microbes that cause chronic infec-
tions persist within host tissues for long periods despite
our best treatment efforts. During the course of these
chronic infections, the causative microbes often change
genetically. For example, a bacterium that commonly
infects the lungs of people with the genetic disease cystic
fibrosis (CF) undergoes several known changes that affect
the growth of this pathogen. However, the causes and
clinical impact of the changes undergone by this and other
chronically infecting microbes are unclear. We show that a
common, early mutation found in bacteria isolated from
chronically infected CF airways renders these bacteria
better able to grow in the nutrients found in CF lung
secretions. Interestingly, these same changes also confer
resistance to several antibiotics used commonly to treat CF
patients. Many of the characteristics conferred by this
mutation are exhibited by other microbes found in chronic
infections, suggesting that adaptation of these microbes
to host tissue nutrient environments may be a common
mechanism of antibiotic resistance in chronic infections.
Metabolic Antibiotic Resistance
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that the impact of lasR mutation on NO2
2 susceptibility was
similar to the effect demonstrated previously for mucoidy [27], as
shown in Fig. 2B for one isolate pair (NCAMT0101-2 and -3).
P. aeruginosa encodes two NO3
2 reductases, one in the bacterial
inner membrane and the other in the periplasm. It was found
previously that, of these two, only the membrane-bound enzyme
wasrequired foranaerobicgrowthofP. aeruginosa[17]. Interestingly,
we found that spontaneous lasR mutants did not emerge during
extended growth on agar medium from strains with transposon
insertions in genes encoding subunits of the membrane-bound
NO3
2 reductase (narJ and narK2), while sectors displaying the
characteristic lasR phenotype arose frequently among strains with
similar mutations in genes encoding the periplasmic enzyme
(PA1173 and napA) (Fig. 2C). Furthermore, the growth advantage
in NO3
2 conferred by lasR mutation (Fig. 1B) was not observed in
the absence of narK genes (narK1narK2lasR, data not shown). Thus,
the membrane-bound NO3
2 reductase was required for both the
growth advantage of lasR mutants in added NO3
2 and for rapid
lasR mutant emergence in vitro. These results functionally link the
growth advantage in NO3
2 conferred by a lasR mutation with the
selection of these mutants, at least in vitro, and perhaps also in the
NO3
2 -rich CF airway [17,18].
Factors that detoxify NO? increase P. aeruginosa lasR
mutant growth
The findings that lasR mutants overproduce the potent
microbicide NO? (Fig. 1E), that they undergo autolysis at high
cell density [11], and that lasR mutants exhibit increased growth
inhibition by exogenous sources of NO? (Fig. 2A) suggested that
factors that detoxify NO? could enrich for lasR mutant growth.
This hypothesis is supported by the observation that the cell death
observed when RhlR mutants are grown anaerobically as biofilms
can be prevented by addition of an NO? scavenger [16]. Similarly,
Figure 1. Mutation in lasR increases denitrification, and leads to the buildup of the toxic metabolite NO?. (A) The reactions that
comprise the dissimilatory denitrification pathway, or the serial reduction of NO3
2 to nitrogen gas, in bacteria. (B) Growth of the wild-type P.
aeruginosa strain PA14 and its derived lasR mutant PA14-lasR::Gm in a chemically defined medium (PN minimal medium) with and without NO3
2
supplementation, under low oxygen mass-transfer conditions. Results representative of three separate experiments. (C) Nitrate (NO3
2) and nitrite
(NO2
2) concentrations in shaken cultures of the indicated strains grown with LB and 5 mM added nitrate. Results shown are the averages of technical
triplicates 6s.d. and are representative of two separate experiments. Slopes for lines fit to each dataset between 4 and 6 minutes were significantly
different with p,0.001 for [NO2
2] and p,0.02 for [NO3
2]. Also shown for reference (inset) are concurrent growth curves for each strain; results
representative of two separate experiments. (D) Rates of degradation of added NO? from a mixture of NO? donors (DEANO and ProliNO) by cells pre-
grown in a sealed chamber in LB prior to donor addition. Results shown are average 6s.d. for technical duplicates and are representative of two
separate experiments. Slopes for lines fit to each dataset between 25 and 100 seconds were significantly different (p,0.02). (E) NO? concentrations in
sealed, stirred LB cultures of the indicated strains during growth with 50 mM added NO3
2. Results are average 6s.d. of three separate experiments.
Slopes for lines fit to each dataset between 4 and 9 minutes were significantly different between wild-type and lasR mutant cultures (p,0.02). For all
experiments shown, similar results were obtained in at least two separate experiments with the Patient 1 early isolate and its derived lasR mutant
(described in Table 1), and complementation with the lasR gene on a plasmid restored wild-type phenotypes (not shown).
doi:10.1371/journal.ppat.1000712.g001
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containing hemoglobin, which scavenges NO? stoichiometrically,
also grew better than did cells farther away from the disk (Fig. 3A).
These results suggest that the presence of an NO? ‘‘sink’’ such as
hemoglobin increased growth of lasR mutant P. aeruginosa.
Some bacteria, including the gram-positive CF bacterial
pathogen Staphylococcus aureus, are known to be relatively resistant
to the effects of NO? as a result of efficient cellular detoxification
mechanisms [24]. Furthermore, we found previously that the
presence of live, but not dead, S. aureus decreased expression of a P.
aeruginosa gene (fhp [25]) involved in NO? degradation [28],
suggesting that S. aureus may detoxify NO? produced by P. aeruginosa.
The catalytic effect of growing S. aureus cells would be predicted to
be even more robust than that of the stoichiometric agent
hemoglobin. Therefore, we compared the growth of lasR mutants
and wild type bacteria in the presence and absence of S. aureus.
The CF pathogen S. aureus increases the growth of
P. aeruginosa lasR mutants, apparently through NO?
detoxification
When grown near S. aureus, lasR mutants exhibited wild-type
growth phenotypes, as manifested by thicker colonies, using either
clinical isolates or laboratory strains of each species (Figs. 3B–C).
Figure 2. Mutation in lasR confers increased susceptibility to nitrosative stress, including acidified NO2
2. (A) Growth rate of PA14 versus
PA14-lasR::Gm in LB in the presence and absence of two amounts of added NO? donor SPER-NO, transiently generating the indicated concentrations
of NO?. Each result representative of at least two separate experiments. (B) Disk diffusion diameters of the indicated strains and isolates on LB agar
buffered to pH 6.5, with disks containing 100 mmol of NaNO2, then incubated for 24 hours at 37uC under aerobic conditions. Average 6s.d. for
triplicate experiments. Similar results were obtained with PA14DlasR, and complementation with a wild-type copy of lasR on a plasmid restored wild-
type phenotypes to lasR mutants (not shown). (C) Spontaneous sectors displaying the lasR phenotype (metallic surface sheen and autolytic flattening,
indicated by black arrows) arise during agar surface growth for 1 week of PA14-derived strains with transposon insertions in genes in the periplasmic
NO3
2 reductase gene cluster (top, genes PA1173 and napA) but not from those with insertion in genes in the membrane-bound NO3
2 reductase
gene cluster (bottom, genes narJ and narK2). Also visible around the lasR mutant sectors is the blue pigment pyocyanin, which is produced at higher
levels by lasR mutant PA14 than by wild-type cells upon extended incubation [61]. Results representative of four separate experiments.
Complementation with a wild-type copy of lasR on a plasmid restored wild-type phenotypes to lasR mutants isolated from sectors (not shown).
doi:10.1371/journal.ppat.1000712.g002
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free culture medium, cell sonicates, and organic extracts of S. aureus
cultures did not exhibit the activity of S. aureus colonies, suggesting
that S. aureus cell activity was required for this phenotypic change.
To further characterize the growth of lasR mutants and its
modification by S. aureus, we inoculated static, liquid cultures
with equal numbers of P. aeruginosa wild-type and lasR mutant
c e l l si nt h ep r e s e n c eo ra b s e n c eo fw i l d - t y p eo rm u t a n tS. aureus
partially defective for NO? degradation (hmp mutants [24]), and
measured the growth of each strain after incubation. As in
previous experiments (e.g., Fig. 2A) [11], P. aeruginosa lasR
mutants grown alone did not have a growth defect relative to
wild-type strains and isolates in these nutrient conditions (not
shown). We found that lasR mutant growth was enhanced by co-
culture with wild-type S. aureus,b u tn o tb yhmp mutant S. aureus
(Fig. 3D). In addition, lasR mutant colonies growing on LB agar
near colonies of hmp mutant S. aureus displayed substantially
more autolysis than did lasR mutants growing near wild-type S.
aureus (not shown), supporting the notion that S. aureus NO?
detoxification is required to impede lasR P. aeruginosa colony
autolysis. These results suggest that the presence of S. aureus,
which commonly co-infects CF airways with P. aeruginosa [29],
encourages the growth of lasR mutant P. aeruginosa by
detoxifying NO?.T h i se f f e c to fS. aureus and other microbes
could contribute to the relatively low tensions of NO? observed
within CF airways [19], which would be predicted to further
Figure 3. lasR mutant P. aeruginosa growth is altered during co-culture with S. aureus, apparently due to detoxification of NO?. (A)
Cells in a lawn of lasR mutant PA14 growing near a disk containing hemoglobin, which stoichiometrically scavenges NO? (as opposed to the catalytic
effect of S. aureus colonies in B–C), do not display the autolysis of cells more distant from the disk, as shown in a photograph from above with
illumination from above (upper) and below (lower). (B) Clinical isolates of lasR mutant P. aeruginosa (black arrows) and S. aureus (white arrows) grown
together on LB agar with 400 mM added KNO3, with lasR colony autolysis and resulting translucency indicated through transillumination of the agar
plate. Black arrows indicate areas of P. aeruginosa lysis and/or sheen, white arrows indicate colonies of S. aureus, and black arrowheads indicate where
lasR colony autolysis is relieved in the presence of S. aureus. (C) Co-culture as in (B) except with laboratory strain PA14-lasR::Gm grown with wild-type
S. aureus Newman strain (colored orange in silico for clarity) after inoculation at a cell ratio of 50:1. Arrows as in (B). (D) Ratios of cell counts of P.
aeruginosa lasR versus wild-type after inoculation of static cultures in liquid LB with 400 mM added KNO3 with equal numbers of each P. aeruginosa
strain followed by growth for 48 hours in the presence and absence of equal cell numbers of the indicated S. aureus strains. Results are averages
6s.d. for triplicate counts and are representative of three separate experiments. Total final cell count was similar in each experiment.
doi:10.1371/journal.ppat.1000712.g003
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mechanism to mitigate the toxic effects resulting from the shift
to nitrate metabolism.
Oxygen utilization is diminished in lasR mutants,
resulting in resistance to oxidative stress
Low molecular oxygen tension and abundant nitrogen oxides
have been observed in CF secretions [18,20]. Furthermore,
deficiency in las signaling has been shown to result in decreased
expression of cytochromes central to oxygen utilization [30].
Therefore, P. aeruginosa lasR mutants could have decreased
utilization of oxygen as an electron acceptor. To test this
hypothesis, we examined rates of oxygen utilization in liquid
(Fig. 4A) and agar-grown (not shown) P. aeruginosa cultures. lasR
mutant cultures exhibited oxygen consumption rates at approx-
imately 40–50% those of wild-type cultures (determined by
comparing slopes of lines fit to each dataset from 1–5 minutes in
Fig. 4A). Aerobic metabolism generates toxic reactive oxygen
species (ROS), including superoxide (O2
2?) [31]. As lasR mutant
cells exhibit decreased rates of oxygen utilization relative to wild-
type cells (Fig. 4A), lasR mutant cells could consequently contain
lower endogenous levels of ROS. Hydroethidine is a specific
Figure 4. lasR mutant P. aeruginosa strains and isolates exhibit lower rates of oxygen utilization and resistance to paraquat,
tobramycin and ciprofloxacin. (A)Change in oxygen concentration during stirred incubation of washed cells of the indicated strains resuspended at
equivalent cell densities in LB with 400 mMK N O 3 at 37uC. Average of 3 experiments 6s.d.; results representative of 3 separate experiments. Slopes for
lines fit to each dataset between 1 and 5 minutes were significantly different (p,0.04). Complementation of lasR mutants with a wild-type copy of lasR
on a plasmid restored wild-type phenotypes (not shown). The difference was no longer statistically significant in the absence of added KNO3 (LB was
shown previously to contain approximately 23 mMN O 3
2 [71]; not shown). (B) Fluorescence yields generated by adding a saturated DMSO solution of
hydroethidine (HE), a probe of superoxide concentration [32], for 5 minutes on lawns of the indicated strains (where plasR indicates complementation
with a wild-type copy of lasR on a plasmid) grownon LB agar. Average 6s.d. of triplicates andrepresentative of five separate experiments; similar results
were obtained in liquid cultures and with clinical isolate pairs for Patient 1 (not shown). (C) Zone diameters of growth inhibition for the indicated clinical
isolates and strains by disks containing 1 mmol of paraquat after 24 hours’ incubation in air at 37uC on LB agar with 400 mMK N O 3. Results shown are
average 6s.d. for triplicates and are representative of .10 separate experiments. Complementation with a copy of lasR on a plasmid restored wild-type
phenotypes to lasR mutants (data not shown). (D) As in (C), except with disks containing 3.75 mg of ciprofloxacin or 3 mg of tobramycin on MH agar and
400 mMKNO3 (thelasRmutantstraintestedfortobramycinsusceptibilitywasPA14-L1,whichdoesnotcontainanengineeredaminoglycosideresistance
gene).Average6s.d. for triplicates.*,p,0.001comparedboth withwild-type andthecomplemented mutant.Nodecreasesinsusceptibility werenoted
with disks of control antibiotics: carbenicillin, tetracycline, aztreonam, and polymyxin. Results with the unmarked deletion strain PA14DlasR were similar
to those with the lasR mutants shown for both (C) and (D). (E) Tobramycin disk diffusion diameters for experiments as in 5d except with the indicated
strains. Experiment at right compares the oxyRkatA-lasR mutant carrying an empty plasmid vector with the same strain carrying the same plasmid but
with a wild-type copy of lasR, and on agar media containing 300 mg/mL carbenicillin for plasmid maintenance. Similar results were observed for disks of
ciprofloxacin (not shown). Results shown are averages 6s.d. for triplicates.
doi:10.1371/journal.ppat.1000712.g004
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2? [32]. Hydroethidine
addition to air-grown agar (Fig. 4B) or liquid (not shown) cultures
of lasR mutants yielded much lower cell fluorescence than did its
addition to wild-type cultures. We demonstrated that cell
permeability was equivalent in wild-type PA14 and lasR mutant
cells using two established methods: one measuring uptake of
ethidium bromide during efflux pump chemical blockade [33] and
another based on the uptake of the fluorescent molecule NPN
without efflux pump inactivation [34] (data not shown). These
results indicate that intracellular O2
2? concentrations are lower in
lasR mutant cells than in wild-type cells. By analogy to the
increased susceptibility of lasR mutants to exogenous nitrosative
stress associated with higher endogenous NO? production (Figs. 1E
and 2A–B), these results suggest that lasR mutant cells would be
more resistant to exogenous sources of oxidative stress, including
redox-cycling agents [31,35].
To test this hypothesis, we measured the response of P. aeruginosa
cultures to the redox-cycling agent paraquat, which reacts with
intracellular oxygen to generate O2
2? [35]. As shown in Fig. 4C,
cultures of lasR mutants (in both laboratory strain and clinical
isolate backgrounds) were more resistant to paraquat and, as with
nitrite susceptibility (Fig. 2B, far right), this effect was present in
lasR mutant clinical isolates after several years of infection (Fig. 4C,
far right). Differences in susceptibility to exogenous hydrogen
peroxide exhibited the same trend, but to a lesser extent (not
shown). Thus, the susceptibility of lasR mutant P. aeruginosa to
exogenous oxidative stress is altered, apparently due to lower
endogenous production of ROS and higher residual capacity for
detoxification. Polyacrylamide gel enzymatic activity assays [31]
demonstrated that lasR mutant cells and their wild-type counter-
parts exhibited similar activities of superoxide dismutases, enzymes
that degrade O2
2? (data not shown), supporting the concept that
the differences in endogenous O2
2? levels, and susceptibility to
paraquat, were due to differences in O2
2? production rather than
differences in O2
2? degradation.
lasR mutants have a growth advantage under conditions
of oxidative stress
The lower endogenous O2
2? concentrations of lasR mutants
indicate that they might have a growth advantage compared with
wild-type cells when grown under conditions of oxidative stress.
To test this hypothesis, agar-suspended cultures were inoculated
with equal numbers of lasR and wild-type cells in the presence of
paraquat, and then the density of each strain was determined in
serial, thin culture slices. Using an oxygen microprobe, oxygen
concentration within these cultures became undetectable within
approximately 2 mm of depth below the surface after 24 hours of
incubation (data not shown). Th i sg r o w t hm e d i u mi sav i s c o u s
gel, limiting the motility and sedimentation of cells and thus
preserving two-dimensional culture structure, resulting in the
establishment of a stableoxygen gradient. In this way, this culture
may reproduce some aspects of CF respiratory secretions, which
are relatively viscous compared to liquid cultures and exhibit
oxygen gradients [20]. Furthermore, as ROS such as O2
2? are
side-products of oxygen-based respiration, ROS are produced at
decreasing amounts with increased depth within the cultures. As
shown in Fig. 5A, lasR cells greatly outcompeted wild-type cells at
more superficial depths, where oxygen was detectable and O2
2?
could be produced upon paraquat exposure. This effect
diminished with increasing depth and, therefore, with lower
oxygen concentration. Thus, under growth conditions in which
superoxide is generated, lasR mutants have a relative fitness
advantage.
The shift to increased nitrate based metabolism by lasR
mutants confers tolerance to antibiotics commonly used
in CF treatment
One condition under which ROS are generated within bacterial
cells is upon exposure to bactericidal antibiotics, including
fluoroquinolones and aminoglycosides, under aerobic conditions
[22,36]. Bacterial killing by both classes of antibiotics has been
shown to be attributable in part to induction of superoxide
production [37]. In addition, efficient aminoglycoside uptake (and
thus bacterial killing) requires aerobic electron transport [23].
Furthermore, a las-regulated P. aeruginosa exoproduct, the Pseudo-
monas quinolone signal, induces an oxidative stress response,
increased cellular ROS, and increased susceptibility to fluoro-
quinolones in P. aeruginosa [38], functionally linking response to
oxidative stress and susceptibility to fluoroquinolones. A relation-
ship between fluoroquinolone susceptibility and oxidative stress is
supported by work in other bacterial species [39], including the
observation that spontaneous mutants in superoxide response
regulators have been selected by exposure of both Escherichia coli
and Salmonella enteritidis to fluoroquinolones [40]. Thus, we
predicted that the lower oxygen utilization rates and increased
resistance to sources of superoxide exhibited by lasR mutants
would result in decreased susceptibility to the fluoroquinolone
ciprofloxacin and the aminoglycoside tobramycin, both of which
are used frequently to treat CF patients [41]. As shown in Fig. 4D,
surface cultures on nitrate-containing agar medium of lasR
mutants were less susceptible to disks containing these drugs.
Agar-suspended cultures in the same medium demonstrated that
these differences were oxygen-dependent (Figs. 5B–C), as with
paraquat (Fig. 5A). These results suggest that, under these culture
conditions, inactivating lasR mutation confers resistance to two of
the antibiotics used most frequently in CF care, tobramycin and
ciprofloxacin. To further investigate the relationship between
oxidative stress and antibiotic resistance, we compared the
susceptibilities to oxidative stress and antibiotics of strains of P.
aeruginosa carrying the double mutation oxyRkatA, or the triple
mutation oxyRkatAlasR. Strains null for oxyR and katA are defective
for the defensive response to oxidative stress [36]; accordingly, the
oxyRkatA mutant exhibited increased susceptibility to paraquat
compared with wild-type (Fig. S1). However, the oxyRkatAlasR
triple mutant was even more resistant to paraquat than was wild-
type, confirming and extending the observation that a lasR
mutation confers resistance to ROS (not shown). Similarly, the
oxyRkatA mutant was more susceptible to tobramycin (Fig. 4E) (as
shown for the oxyR single mutant and the aminoglycoside
gentamicin [36]) and to ciprofloxacin (not shown) than was wild-
type; as with paraquat, the oxyRkatAlasR triple mutant exhibited
resistance to each of these drugs, an effect that was reversed by
complementation with a wild-type copy of lasR on a plasmid
(Fig. 4E and data not shown). These results indicate that lasR
mutation confers resistance to these two antibiotics through its
effects on respiratory activity and oxidative stress response. As lasR
mutant strains and isolates also exhibit increased tolerance to some
b-lactams due to increased b-lactamase activity [11], these results
suggest that the emergence of lasR mutant isolates during chronic
infections could adversely impact the clinical response to all three
of the antibiotic classes used most commonly during standard CF
treatment (b-lactams, fluoroquinolones, and aminoglycosides).
The recent discovery [42] that increased bacterial production of
NO? (which is increased by LasR inactivation, Fig. 1E) confers
additional protection against a wide variety of antibiotics,
including b-lactams, quinolones, and aminoglycosides, further
supports this possibility.
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In this work, P. aeruginosa isolates with inactivating mutations in
the AHL-responsive transcriptional regulator LasR exhibited a
profound growth advantage with nitrogen substrates found in the
CF airway. These differences are attributable to lasR-dependent
increased utilization of nitrogen oxides and decreased utilization of
oxygen. This metabolic shift results in an increase in the
production of the RNS NO?, and a corresponding decrease in
the ROS O2
2?, the latter of which is associated with decreased
susceptibility in our conditions to at least two antibiotics used
frequently in treating CF lung infections. This growth advantage
in conditions characteristic of CF airways, and the resulting
antibiotic resistance, may explain the observed high prevalence of
Figure 5. Resistance of lasR mutant P. aeruginosa to tobramycin and ciprofloxacin is oxygen-dependent. (A) Colony counts from serial
slices of an agar-suspended culture with LB+400 mM KNO3 containing 5 mM paraquat inoculated with equal numbers of cells of PA14 and a derived
lasR mutant (PA14-lasR::Gm) and incubated for 48 hours. (B) The same experiment as in (A), except with 1 mg/mL tobramycin instead of paraquat, and
using PA14-L1 (because this lasR mutant lacks an aminoglycoside resistance cassette). (C) The same experiment as in (B), except with 0.25 mg/mL
ciprofloxacin and with PA14-lasR::Gm. All results representative of at least 3 independent experiments. No differences in cell density were noted in
the absence of antibiotics or paraquat under these conditions after 48 hours of growth (not shown), in agreement with liquid growth findings [11].
doi:10.1371/journal.ppat.1000712.g005
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patients whose airways contain these mutants [8].
The metabolic changes that occur upon lasR inactivation would
be predicted to favor growth of lasR mutants arising spontaneously
in the CF airway due to the confluence of selective forces
encountered in this environment. For example, the abundant
NO3
2 and NO2
2 [17,18] and low oxygen tensions [20] found in
CF secretions, as well as the relatively low NO? levels [18], would
provide optimal metabolic conditions for lasR mutant selection. As
suggested previously [43], P. aeruginosa likely adapts to a continuum
of different oxygen tensions, with variation in the relative ratio of
oxygen and nitrate utilization. Inactivating mutations in lasR may
confer advantages in a variety of these microenvironments found
in the CF lung. Also contributing to the beneficial nature of this
environment for lasR mutant growth is the presence of NO?-
detoxifying microbes, such as S. aureus and perhaps anaerobic
bacteria, the latter of which were recently found to occupy CF
secretions at high densities [44]; it should be noted that, while
contact of lasR mutant P. aeruginosa with wild-type P. aeruginosa was
also shown previously to reverse autolysis and sheen [11], it is not
yet clear whether the mechanism of this effect is similar to that of
S. aureus. The availability of amino acids as nutrient sources in CF
secretions [13] would provide an additional selective pressure for
lasR mutant growth [11]. Similarly, lasR mutants are relatively
resistant to sources of oxidative stress, including tobramycin and
ciprofloxacin (Figs. 4D–E), two antibiotics that, along with
ceftazidime (to which lasR mutants are also relatively tolerant
due to augmented b-lactamase activity [11]), are among the
antibiotics used most commonly in CF treatment [41]. Although
other sources of ROS are present in CF airways, such as H2O2
from host cells [36], whether exogenously adding these molecules
to P. aeruginosa effectively confers intracellular oxidative stress is not
as clear as is is the effect of the above antibiotics [22,23]. While the
results presented here demonstrate that nutrient conditions
(particularly relating to oxygen and nitrogen oxides) are sufficient
to enrich for lasR mutant growth in vitro, the frequent treatment of
CF patients with the above antibiotics likely provides additional
selection for these mutants, resulting in a complex dynamic
between the CF airway nutrient environment, P. aeruginosa
adaptation, therapy, and pathophysiology. These ideas are
summarized in the model in Fig. 6.
There are multiple therapeutic and pathophysiologic implica-
tions of the model in Fig. 6. For example, assuming that P.
aeruginosa infection leads to airway inflammation, and thus to
obstructive lung disease, as suggested by current models of CF
pathogenesis [41], the growth advantage of lasR mutant cells
within the CF airway would be predicted to render such mutants
more pathogenic to CF patients by virtue of higher cell density and
greater consequent inflammation. (It should be noted that while
lasR mutant P. aeruginosa strains were shown to be less pathogenic
in animal models of short-term respiratory infection [45], those
models may not accurately reflect the pathogenic mechanisms of
chronic CF airway infection, during which many ‘‘acute’’
virulence factors are not expressed [46]). This effect may
contribute to the observed association between lasR mutant CF
airway infection and worse lung function [8]. Furthermore, the
clinical response to standard antibiotic therapy in patients infected
with lasR mutants would be predicted to be poor relative to
patients with wild type isolates, perhaps further contributing to the
clinical impact and rendering eradication increasingly difficult [8].
Thus, the presence of lasR mutants in CF respiratory cultures may
be of prognostic value, and aggressive, directed treatment of these
mutants upon isolation (i.e., through the expanded use of
monobactams, tetracyclines, or polymyxin in the case of lasR
mutant infection) or with regimens that do not select for their
growth may lead to improved outcomes.
While recent publications have shown that quorum sensing
regulates the expression of denitrification genes [14,15,16] and
oxygen metabolic genes [30] at the transcriptional level, the
mechanism of the distinct metabolic behaviors of lasR mutant and
wild-type cells is likely to be as complex as the quorum sensing
system itself. In P. aeruginosa, quorum sensing involves at least three
parallel signaling systems, at least four different signal receptors,
and regulation by diverse environmental cues [14,47,48].
However, some mechanistic clues are evident from our results.
Previously, we showed that the two-component metabolic
regulatory system CbrAB contributes to the metabolic phenotypes
of lasR mutant clinical isolates of P. aeruginosa [11]; mutants in this
system have decreased capacities to use amino acids as nitrogen
sources [49], and lasR mutant isolates have upregulated expression
of the transcriptional metabolism regulator cbrB [11]. The current
results also suggest an additional mechanism for the growth
advantage of lasR mutant P. aeruginosa in specific amino acids (most
markedly with phenylalanine, but also with other aromatic and
branched-chain amino acids [11]). Many enzymes that metabolize
amino acids are inactivated by reactive oxygen species (ROS),
Figure 6. A model for metabolic changes in CF-adapted lasR mutant isolates of P. aeruginosa. According to the model, patients are initially
infected with environmental isolates carrying wild-type copies of the lasR gene (left). These isolates have relatively high utilization of oxygen
(activities indicated by the sizes of the green arrows) and lower utilization of nitrogen oxides (NOx). Selective pressures encountered in the host,
including abundant host NO3
2 and amino acids (AA), low host NO?, the presence of other bacterial species that metabolize NO?, reduced O2
concentrations, and treatment with b2lactams or antibiotics that generate ROS, favor the emergence of lasR mutant isolates with higher utilization
of nitrates and lower utilization of oxygen. This metabolic shift confers a growth advantage in the nutrient conditions in the CF airway, including
abundant NO3
2, and relative resistance to the antibiotics used most frequently to treat CF patients.
doi:10.1371/journal.ppat.1000712.g006
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phenylalanine hydroxylase [50,51]. Therefore, cells with lower
intracellular concentrations of ROS, such as lasR mutants (Fig. 4B),
would be predicted to be better able to utilize amino acids such as
phenylalanine as nutrient sources. Additionally, the las system is
involved in regulating the levels and timing of production of a
family of hydroxyalkylquinoline (HAQ) molecules [52], including
the compounds 4-hydroxy-2-heptylquinoline (HHQ), the overpro-
duction of which generates the sheen characteristic of lasR mutant
colonies [11]; its N-oxide HQNO, which is a redox-cycling agent
[29]; and the Pseudomonas quinolone signal (PQS) [52]. Exposure to
PQS was shown to modify P. aeruginosa responses to reactive
oxygen species and ciprofloxacin [38], suggesting a functional
linkage between HAQs, oxidative stress responses, and suscepti-
bility to fluoroquinolones. Therefore, these quinolines may
regulate metabolic properties in both source and neighboring
cells, and temporal differences in their production resulting from
LasR inactivation may contribute to the observed metabolic
changes.
Numerous explanations have been offered for the identification
of lasR mutant P. aeruginosa in diverse clinical and experimental
conditions [10,11,12,53,54,55,56,57,58,59,60]. For example, in
experimental growth medium in which P. aeruginosa growth
requires the production of lasR-regulated protease, lasR mutants
emerge that ‘‘cheat’’ from the protease produced by wild-type
strains [59,60]. However, CF sputum is abundant in free amino
acids [13] (upon which P. aeruginosa lasR mutants can grow without
requiring protease [11,59]), and it has been shown that both
laboratory strains [61] and clinical isolates [12] may produce
protease in the absence of a functional las system. Furthermore,
lasR mutants are frequently isolated from CF sputum without
detectable wild-type co-isolates [2,11]. These findings suggest that
cheating alone does not explain the high prevalence of lasR
mutants among people with CF. Alternatively, it has been
suggested that lasR mutants emerge due to physiological
characteristics that confer relative fitness advantages in specific
growth conditions [11,56]. The current results support the
hypothesis that lasR mutant P. aeruginosa have a growth advantage
in nutrient and antibiotic conditions found in the CF airway (as
summarized in Fig. 6). While it is unclear which of these forces,
antibiotics or nutrients, predominates in vivo in selecting for
inactivating lasR mutations, their combination would be predicted
to exert powerful pressure against LasR function.
The hypothesis that P. aeruginosa adaptation to the CF airway is
driven in large part by metabolic forces found in CF airway secretions
is supported by findings with other adapted mutants from chronic
infections. For example, mucoid P. aeruginosa strains and isolates also
exhibit upregulated NO3
2 metabolism relative to non-mucoid P.
aeruginosa and, as a result, are more susceptible than nonmucoid
isolates to acidified NO2
2 [27]. Furthermore, the mucoid phenotype
is promoted by hypoxia [20]. Similarly, P. aeruginosa isolates with
another CF adaptation, mutations that upregulate the glucose-6-
phosphate dehydrogenase gene zwf,c o n f e rr e s i s t a n c et oo x i d a t i v e
stress and paraquat [62,63]. The enrichment for lasR mutant P.
aeruginosa, with growth advantages in CF airway conditions, by S.
aureus is also reminiscent of the reverse interaction: the selection of S.
aureus metabolic mutants,known as small-colony variants (SCVs), due
to co-culture with wild-type P. aeruginosa [29]. S. aureus SCVs are
defective for aerobic growth, are resistant to aminoglycoside
antibiotics such as tobramycin, and frequently exhibit both increased
expression of denitrification genes [64] and associated increased
susceptibility to NO2
2 [65], much like lasR mutant P. aeruginosa.T h e
symmetry of this S. aureus-P. aeruginosa relationship, in each direction
favoring the growth of antibiotic-resistant, metabolic mutants with
decreased aerobicactivity, further suggests a common mechanismfor
selection during chronic CF infections, and perhaps during many
other chronic infections, driven by the metabolic forces present in
host tissues. In support of this hypothesis, the likelihood of persistent,
latent infection by the respiratory pathogen Mycobacterium tuberculosis is
thought to be determined in large part by the lung metabolic milieu,
particularly the relative ambient concentrations of nitrogen and
oxygen species [66]. Similarly, the pathogenic fungus Cryptococcus
neoformans exhibits early metabolic adaptations in animal models of
chronic pulmonary infection, including altered responses to nitrosa-
tive stress and superoxide [67]. As with M. tuberculosis [68], these
findingssupporttheconceptthatchronicCFairwayinfectionswithP.
aeruginosa could be amenable to therapies that increase airway
nitrosative stress. Such therapies could include inhaled NO2
2 [27] or
L-arginine [19], two treatments already being examined as candidate
CF treatments. Our results supportthe utility of these treatments both
in preventing P. aeruginosa adaptive changes associated with advanced
lung function decline [7,8] and that may be attributable to current
antibiotic regimens (Fig. 6), as well as in treating patients with
advanced infection in which these adaptations have already occurred.
In summary, the nutrient conditions characteristic of the CF
airway select for growth of lasR mutant P. aeruginosa, resulting in
decreased susceptibility to antibiotics without the need for
antibiotic exposure. Adaptation of many microbes to new
environments during chronic infections may commonly result in
metabolic changes that impact response to antibiotics. This
scenario may be particularly relevant for opportunistic pathogens
such as P. aeruginosa, many of which naturally occupy competitive
and nutrient-poor environmental niches like soil and water, as they
adapt to the specific nutrient conditions found in host environ-
ments such as the nitrogen-rich CF airway.
Materials and Methods
Bacteria
Table 1 lists the bacterial strains and isolates used in this work,
except for the strains carrying transposon insertion mutations in
nitrate metabolic genes, which were obtained from the PA14
transposon insertion mutant library [69]. The origins of all strains
and isolates are described in the references provided in Table 1,
except for the narK1K2 and narK1K2lasR mutants, described
below.
Mutant construction and plasmids
Each deletion in the lasR, narK1K2 and narK1K2lasR mutants
was generated using allelic exchange with sacB-containing
counterselectable gene replacement vectors using sucrose counter-
selection essentially as described [70]. Briefly, the lasR gene was
entirely deleted from the chromosome except for the start and stop
codon, using the plasmid sacB-based pEX18Gm for integration
and excision. The narK1-narK2 genes, which are organized
tandemly as an operon, were deleted as a one continuous stretch
of DNA using identical methods, both in wild-type PA14 as well as
the lasR mutant background. The deletion removed the narK
coding sequence beginning from the 30
th codon of narK1 until the
462
nd codon of narK2, leaving the first 29 codons of narK1 and the
last 7 codons of narK2 intact.
The plasmid pUCPSK-lasR was the kind gift of Eric De ´ziel and
was used for complementation of lasR deficient strains and isolates
as described [61].
Growth conditions and chemicals
Except where indicated, all cultures were inoculated from LB
overnight cultures of bacteria or cells suspended from LB agar
Metabolic Antibiotic Resistance
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KNO3 (Sigma) except where indicated otherwise. Phosphate
buffered LB agar was prepared as described [27]. Chemically
defined PN medium was prepared as previously described [24],
and consists of a phosphate buffer supplemented with a carbon
source (glucose), nitrogen and sulfur sources [(NH4)2SO4 and
MgSO4], amino acids, nucleic acid bases, and vitamins (thiamine,
niacin, biotin, and pantothenic acid).
Chemicals
Hemoglobin, hydroethidine, tobramycin, paraquat (methylvio-
logen dichloride hydrate), potassium nitrate, and sodium nitrite
were obtained from Sigma. NO donors DEANO (DEA-NON-
Oate) and ProliNO (Proli-NONOate) were purchased from AG
Scientific (San Diego, CA) and SperNO was obtained from
CalBiochem (San Diego, CA). Ciprofloxacin was from Biochem-
ika/Sigma. Prepared antibiotic disks with tobramycin, kanamycin,
gentamicin, carbenicillin, tetracycline, aztreonam, ceftazidime,
and polymyxin B were from Becton Dickinson. Growth media and
agar were from Becton Dickinson & Co.
Growth assays
Growth of cells in the indicated liquid media was measured
optically using a BioScreen C Microbiology Microplate reader
(Growth Curves USA, Piscataway, NJ) without shaking (except
immediately prior to readings), a condition that limits oxygen
mass-transfer. Assays to look for mutant sectors were performed by
inoculating 10 ml drops of 1:10-diluted overnight cultures on LB
with 400 mM KNO3, followed by incubation at 37uC for 24 hours
and then at room temperature for up to approximately 1 month
thereafter.
Assays for denitrification activity and NO2
2 susceptibility
NO? was quantified using an ISO-NOPMC Mark II electrode
(WPI Instruments, Fl) and dissolved oxygen was measured in
parallel using a Clark-type electrode MLT1120 (ADI Instruments)
with standard curves as per manufacturer instruction. Data from
both probes were analyzed through an Analog Adapter MLT1122
(ADI Instruments). NO2
2 disk diffusion on acidified, buffered LB
agar was performed as described [27], except that all incubations
were performed with aerobic growth.
Assay for oxygen utilization
Respiration rates in liquid cultures were measured by
resuspending PBS-washed cells in prewarmed LB with 400 mM
KNO3 in a microrespiration system (Unisense AS, Denmark).
Calibrations were performed according to manufacturer’s instruc-
tions using air-purged and argon-purged growth medium.
Hydroethidine assay
Fluorescence after hydroethidine addition to lawns of cells
during growth on LB agar (similar results were obtained with and
without added NO3
2) was measured using excitation/emission
wavelengths of 396/570 nm [32], followed by photography and
quantitation using NIH ImageJ software (NIH, Bethesda, Md,
http://rsb.info.nih.gov/ij/).
Agar growth assay
Agar-suspended cultures were grown in 0.9% LB agar
inoculated with equal cell numbers of all cell types- approximately
10
5 CFU of the indicated strains (resulting in a final cell density of
approximately 2610
3 CFU/mL), except when indicated other-
Table 1. List of strains used in the described experiments.
Strain name Description References
P. aeruginosa
PA14 Laboratory strain with phenotypic and genotypic features that resemble many clinical isolates [11]
PA14-lasR::Gm Engineered mutant of PA14 with a gentamicin resistance cassette inserted into the lasR gene [11]
PA14-L1 Spontaneous lasR mutant of PA14 without an antibiotic resistance marker [11]
PA14DlasR PA14 with an unmarked deletion in lasR This study
AMT0023-30 CF clinical isolate with wild-type lasR allele from a young patient (previously referred to as Patient 1 Early) [2,11]
AMT0023-30-L1 Spontaneous lasR mutant of AMT0023-30 [11]
AMT0023-94 CF clinical isolate from the same patient as AMT0023-30 but 8 years later with a naturally-occurring lasR mutation
(previously referred to as Patient 1 Late)
[2,11]
NC-AMT0101-3 CF clinical isolate with wild-type lasR allele from a second young patient [2,11]
NC-AMT0101-2 CF clinical isolate collected from the same patient as NC-AMT0101-3 but 8.6 years later with wild-type lasR allele and
mucoid phenotype
[2,11]
NC-AMT0101-1 CF clinical isolate from the same culture as NC-AMT0101-2 with naturally-occurring mutant lasR allele, nonmucoid. [2,11]
PAO1 Laboratory strain [36]
oxyR PAO1 with unmarked deletion in oxyR [36]
oxyRkatA Above oxyR mutant with katA::Gm [36]
oxyRkatAlasR lasR mutant that emerged spontaneously during growth for 3 days on LB agar from oxyRkatA with the mutation G191V This study
narK1narK26lasR Strains with clean deletions in narK1 and narK2 with and without clean deletions in lasR This study
S. aureus
S. aureus Newman strain Laboratory strain of S. aureus [24]
hmp Derived mutant S. aureus Newman with the gene that encodes the NO* detoxifying flavohemoprotein deleted [24]
AMT0064-6 Clinical CF isolate of S. aureus [29]
doi:10.1371/journal.ppat.1000712.t001
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each case, the prepared agar was inoculated with bacteria when
the medium had cooled after autoclaving to approximately 37uC
but before gelling. The medium was then poured into 10 mL
syringes from which the port ends had been removed, leaving an
open end, which was loosely covered for incubation. After
incubation, the plunger of the syringe was depressed slowly,
ejecting a cylinder of culture. Serial, 1.5 mm slices of culture were
removed and added to 1 mL each of sterile PBS, and vortexed for




2 production was measured using the Griess Reagent
System kit (Promega, Madison WI). Nitrate was quantified
enzymatically using a commercially available reagent set (R-
Biopharm, Marshall, MI). Rates of NO? degradation were
determined as previously described [24]; briefly, five milliliter
cultures in PN medium were grown by shaking at 37uCt oa n
OD660<0.4. Cells were then resuspended to 1610
8 cfu ml21i n
8 ml final volume. A two-hole rubber stopper sealed with Parafilm
enclosed the cell suspension in an 8 ml glass vial with no gaseous
headspace. Cells were stirred vigorously at 37uC as ProliNO was
added through one open port to 1 mM. The resulting immediate
release of approximately 2 mMN O ? followed by the gradual decay
of detectible signal was recorded and normalized to the fraction of
initial [NO?]. Measurements were performed in triplicate for each
strain tested. NO? susceptibility was determined by measuring the
lag in growth after bacterial cultures in LB medium were
supplemented with 0.5 or 2.5 mM SperNO (t1/2=39 min at
37uC).
Oxygen metabolism in deep-agar cultures
Deep-agar cultures inoculated with serial dilutions of P.
aeruginosa lasR and wild-type cells in LB-0.9% agar with and
without 400 mM KNO3 and with and without paraquat were
grown overnight at 37uC. Oxygen concentrations were subse-
quently recorded using a microsensor setup (OX 10 oxygen
microsensor, PA 2000 picoammeter, both from Unisense AS,
Denmark) at 37uC in a preconditioned water bath. Data were
recorded using SensorTrace Basic software (Unisense). The probe
was advanced into the agar, and measurements taken, in 50 mm
increments.
Statistics
Differences between experimental measurements were comput-
ed using unpaired, two-tailed Student’s t-tests.
Supporting Information
Figure S1 lasR inactivating mutation decreases susceptibility to
paraquat. Experiment performed as described in Fig. 4C, except
with the indicated strains. Results shown are averages 6s.d.
for three replicates and are representative of two separate
experiments.
Found at: doi:10.1371/journal.ppat.1000712.s001 (0.13 MB TIF)
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